In CA, good bioproduction news balances bad

California bioproduction is expanding, showing the potential for manufacturing ramp-ups in recession-hit areas. More CEOs surveyed in the BayBio Report expect to increase manufacturing in-state as opposed to outside the state. Yet more CEOs also plan to cut manufacturing operations in California than in other regions. Article

Suggested Articles

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.

It took four tries over four years, but Perrigo has finally gotten FDA approval of its generic of Teva’s tricky-to-make ProAir HFA asthma inhaler.